Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $494.6000 (-0.88%) ($494.6000 - $506.8100) on Mon. Feb. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 32 | Latest Price | $494.6000(-0.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -4.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(43%) SPLV(37%) DIA(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -0.88% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) IGOV(-7%) VXX(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $515.51 | 5 Day Moving Average | $496.33(-0.35%) | 10 Day Moving Average | $505.29(-2.12%) | 20 Day Moving Average | $515.51(-4.06%) | To recent high | -13% | To recent low | 5.2% | Market Cap | $52.442b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |